Tech Company Financing Transactions

Nurix Therapeutics Funding Round

Nurix Therapeutics closed a $2.1 million investment round on 1/3/2014. Investors included private investors.

Transaction Overview

Company Name
Announced On
1/3/2014
Transaction Type
Venture Equity
Amount
$2,075,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes are to be used for working capital. SEC regulatory filing. Contact technology company for solicitation details, if applicable.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1700 Owens St. 205
San Francisco, CA 94158
USA
Email Address
Overview
Nurix Therapeutics (Nasdaq: NRIX) is focused on the discovery and development of small molecule inhibitors of ubiquitin ligases to treat a broad range of proliferative and degenerative diseases.
Profile
Nurix Therapeutics LinkedIn Company Profile
Social Media
Nurix Therapeutics Company Twitter Account
Company News
Nurix Therapeutics News
Facebook
Nurix Therapeutics on Facebook
YouTube
Nurix Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Arthur Sands
  Arthur Sands LinkedIn Profile  Arthur Sands Twitter Account  Arthur Sands News  Arthur Sands on Facebook
Vice President
Jean Chang
  Jean Chang LinkedIn Profile  Jean Chang Twitter Account  Jean Chang News  Jean Chang on Facebook
Vice President
Cristiana Guiducci
  Cristiana Guiducci LinkedIn Profile  Cristiana Guiducci Twitter Account  Cristiana Guiducci News  Cristiana Guiducci on Facebook
VP - Bus. Development
Pierre Beaurang
  Pierre Beaurang LinkedIn Profile  Pierre Beaurang Twitter Account  Pierre Beaurang News  Pierre Beaurang on Facebook
VP - Finance
Hans Houte
  Hans Houte LinkedIn Profile  Hans Houte Twitter Account  Hans Houte News  Hans Houte on Facebook
VP - General Counsel
Christine Ring
  Christine Ring LinkedIn Profile  Christine Ring Twitter Account  Christine Ring News  Christine Ring on Facebook
VP - R & D
Gwenn Hansen
  Gwenn Hansen LinkedIn Profile  Gwenn Hansen Twitter Account  Gwenn Hansen News  Gwenn Hansen on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/3/2014: Tute Genomics venture capital transaction
Next: 1/3/2014: DNAnexus venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary